TREATMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA ACCORDING ON THE SPECIFIC MOLECULAR FEATURES OF THE TUMOR (A LITERATURE REVIEW)

TREATMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA ACCORDING ON THE SPECIFIC MOLECULAR FEATURES OF THE TUMOR (A LITERATURE REVIEW)

Despite the achieved progress in radiotherapy, chemotherapy, and surgery, head and neck squamous cell carcinoma (HNSCC) still remains the sixth most common cause of death from cancer worldwide. The division of HNSCC into 2 large groups with different survival rates is a significant achievement made...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. I. Stukan, R. A. Murashko, V. N. Bodnya, O. Yu. Chukhray, E. V. Dulina
Format:	Article
Language:	Russian
Published:	ABV-press 2017-11-01
Series:	Опухоли головы и шеи
Subjects:	head and neck squamous cell carcinoma whole-exome sequencing human papillomavirus type 16 mutations in tumor suppressors target therapy ways of hnscc differentiation
Online Access:	https://ogsh.abvpress.ru/jour/article/view/291
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK: NEW AVENUES OF TREATMENT?
by: T. Braunschweig, et al.
Published: (2015-04-01)

Strategies for Anticancer Treatment in p53-Mutated Head and Neck Squamous Cell Carcinoma
by: Bi-He Cai, et al.
Published: (2025-05-01)

Cottontail Rabbit Papillomavirus (CRPV) Related Animal Models for Head and Neck Cancer Research: A Comprehensive Review of the Literature
by: Michael Bette, et al.
Published: (2024-10-01)

Analysis of divergent gene expression between HPV + and HPV- head and neck squamous cell carcinoma patients
by: Kasturika Shankar, et al.
Published: (2025-05-01)

Clinical significance of P16-positive status and high index of proliferative activity in patients with oropharyngeal squamous cell carcinoma
by: A. I. Stukan, et al.
Published: (2020-04-01)

Risk factors for head and neck squamous cell carcinoma in disease pathogenesis and prognosis: the importance of smoking cessation and the concept of harm reduction
by: A. I. Stukan, et al.
Published: (2024-04-01)

Evidence of mutations in tumour suppressor genes among oral cancer in Naswar, smokeless tobacco users
by: Fatima Iqbal, et al.
Published: (2025-06-01)

Integrating metabolism gene clusters and tumor immune microenvironment in head and neck squamous cell carcinoma
by: Meina Lian, et al.
Published: (2025-06-01)

INDUCTION CHEMOTHERAPY IN ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA: A REAL-WORLD DATA STUDY
by: Matheus Yung Perin, et al.
Published: (2025-05-01)

Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma
by: Sandra Llop, et al.
Published: (2024-11-01)

Analysis of Selected Small Proline-Rich Proteins in Tissue Homogenates from Samples of Head and Neck Squamous Cell Carcinoma
by: Dariusz Nałęcz, et al.
Published: (2025-06-01)

Nivolumab resistance in head and neck squamous cell carcinoma patients and future perspectives
by: Karolina Buchajska, et al.
Published: (2025-04-01)

Human papilloma virus infection drives unique metabolic and immune profiles in head and neck and cervical cancers: implications for targeted therapies and prognostic markers
by: Saira Hamid, et al.
Published: (2025-05-01)

Peripheral immune and inflammatory markers as predictors of neoadjuvant immunotherapy response in head and neck squamous cell carcinoma
by: Wendi Li, et al.
Published: (2025-12-01)

Adaptive immune response in pathogenesis and treatment of head and neck squamous cell carcinoma: the influence of immunosuppression factors and gender
by: A. I. Stukan, et al.
Published: (2022-12-01)

Duchenne muscular dystrophy gene product expression is associated with survival in head and neck squamous cell carcinoma
by: Leanne Jones, et al.
Published: (2025-03-01)

Postoperative complications following salvage neck dissection after (chemo)radiotherapy for head and neck squamous cell carcinoma: which patients are at high risk?
by: Arash Navran, et al.
Published: (2025-05-01)

30-hydroxygambogic acid increases the efficacy of cisplatin in an HPV+ head and neck cancer in vivo model
by: Sonia N. Whang, et al.
Published: (2025-08-01)

Pathological regression patterns following neoadjuvant chemo-immunotherapy in head and neck squamous cell carcinoma: a pilot study
by: Dikan Wang, et al.
Published: (2025-08-01)

A Single-Cell Transcriptome Atlas of Epithelial Subpopulations in HPV-Positive and HPV-Negative Head and Neck Cancers
by: Mary C. Bedard, et al.
Published: (2025-03-01)

Epidermal Growth Factor Receptor Mutated Lung Cancer Presenting as Synchronous with a Recurrent Nonhuman Papillomavirus-Related Head-and-Neck Squamous Cell Carcinoma
by: Daphne Fonseca, et al.
Published: (2021-07-01)

Radiotherapy outcomes and risk factors for young patients with head-and-neck squamous cell carcinomas: a matched-pair analysis
by: Jiadai Zou, et al.
Published: (2025-04-01)

Gene expression profiling and pathway analysis in head and neck squamous cell carcinoma: focus on disulfidptosis
by: Yajun Tong, et al.
Published: (2025-04-01)

Advances in neoantigen-based immunotherapy for head and neck squamous cell carcinoma: a comprehensive review
by: Manzhu Jiang, et al.
Published: (2025-05-01)

Editorial: Early diagnosis in head and neck cancer: advances, techniques, and challenges
by: Natalia Koerich Laureano, et al.
Published: (2025-07-01)

Systematic analysis of chemotherapy, immunotherapy, and combination therapy in Head and Neck Squamous Cell Carcinoma (HNSCC) clinical trials: Focusing on overall survival and progression-free survival outcomes
by: Priya Ganesan, et al.
Published: (2024-12-01)

Estimation of the prevalence of HPV-positive squamous cell carcinoma of the oropharynx on the example of a separate sample in the Russian Federation
by: B. G. Pkheshkhova, et al.
Published: (2022-04-01)

Oxidative Stress and Dietary Antioxidants in Head and Neck Cancer
by: A Jeong You, et al.
Published: (2025-04-01)

Role of Human Papilloma Virus in Carcinogenesis of Head and Neck Squamous Cell
by: Sukri Rahman, et al.
Published: (2024-01-01)

The correlation between MTHFD2 and the tumor microenvironment in head and neck squamous cell carcinoma
by: SHI Zhenxiang, et al.
Published: (2024-03-01)

Update: Immunotherapeutic Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma
by: Fangdi Sun, et al.
Published: (2025-05-01)

Patient-Derived Cancer-Associated Fibroblasts Support the Colonization of Tumor Cells in Head and Neck Squamous Cell Carcinoma
by: Julia Federspiel, et al.
Published: (2025-02-01)

The results of immunotherapy in patients with recurrent and metastatic human papilloma virus positive head and neck squamous cell carcinoma
by: A. V. Ignatova, et al.
Published: (2024-06-01)

Efficacy and safety of immunotherapy for head and neck squamous cell carcinoma: a meta-analysis of randomized clinical trials
by: Cailing Jiang, et al.
Published: (2025-01-01)

The association between body mass index and efficacy of pembrolizumab as second‐line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma
by: Xinyi Zhang, et al.
Published: (2023-02-01)

Chemotherapy with cetuximab in head and neck squamous cell carcinoma: immunological aspects and markers of treatment effectiveness in clinical practice
by: A. I. Stukan, et al.
Published: (2024-06-01)

Mechanism of Fas-associated protein with death domain in promoting proliferation of head and neck squamous cell carcinoma cells
by: CHEN Yinan, et al.
Published: (2025-04-01)

Unraveling the immunomodulatory role of TIM-3 in head and neck squamous cell carcinoma: implications for targeted therapy
by: Shuang Xu, et al.
Published: (2025-05-01)

ASSESSMENT OF BLOOD SERUM PROTEOME IN PATIENTS WITH SQUAMOUS CELL HEAD AND NECK CARCINOMA
by: G. V. Kakurina, et al.
Published: (2016-02-01)

Bcl6 controls the stability and suppressive function of regulatory T cells in head and neck squamous cell carcinoma
by: Shuqiong Wen, et al.
Published: (2025-07-01)